共 50 条
- [4] Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 105 - 112
- [6] Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia European Journal of Clinical Pharmacology, 2024, 80 : 105 - 113